Quantification of afatinib, alectinib, crizotinib and osimertinib in human plasma by liquid chromatography/triple-quadrupole mass spectrometry; focusing on the stability of osimertinib-Reference-Cited by-同舟云学术

Quantification of afatinib, alectinib, crizotinib and osimertinib in human plasma by liquid chromatography/triple-quadrupole mass spectrometry; focusing on the stability of osimertinib

Published:2019-04 Issue: Volume:1113 Page:37-44
ISSN:1570-0232
Container-title:Journal of Chromatography B
language:en
Short-container-title:Journal of Chromatography B

Author:

Veerman G.D. Marijn,Lam Mei H.,Mathijssen Ron H.J.,Koolen Stijn L.W.,de Bruijn Peter

Publisher

Elsevier BV

Subject

Cell Biology,Clinical Biochemistry,Biochemistry,General Medicine,Analytical Chemistry

Reference22 articles.

1. Targeted therapy for non-small cell lung cancer: current standards and the promise of the future;Chan;Transl. Lung Cancer Res.,2015

2. Management of advanced non-small cell lung cancers with known mutations or rearrangements: latest evidence and treatment approaches;Shea;Ther. Adv. Respir. Dis.,2016

3. Scientific advances in lung cancer 2015;Tsao;J. Thorac. Oncol.,2016

4. Approval Rapport GILOTRIF™ (Afatinib) Reference ID: 3340037;F.D.A. U.S.,2013

5. Rebiopsy of lung cancer patients with acquired resistance to EGFR inhibitors and enhanced detection of the T790M mutation using a locked nucleic acid-based assay;Arcila;Clin. Cancer Res.,2011

Cited by 54 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Simultaneous determination of icotinib, osimertinib, aumolertinib, and anlotinib in human plasma for therapeutic drug monitoring by UPLC-MS/MS;Journal of Pharmaceutical and Biomedical Analysis;2024-12

2. Development and validation of an ultra‐performance liquid chromatography–tandem mass spectrometry method to quantify the small molecule inhibitors adagrasib, alectinib, brigatinib, capmatinib, crizotinib, lorlatinib, selpercatinib, and sotorasib in human plasma;Biomedical Chromatography;2024-08-13

3. AFATINIB-A COMPREHENSIVE REVIEW OF ANALYTICAL METHODS DEVELOPED IN PHARMACEUTICALS AND BIOLOGICAL MATRICES;International Journal of Applied Pharmaceutics;2024-07-07

4. Determination of Pralsetinib in Human Plasma and Cerebrospinal Fluid for Therapeutic Drug Monitoring by Ultra-performance Liquid Chromatography-Tandem Mass Spectrometry (UPLC-MS/MS);Anti-Cancer Agents in Medicinal Chemistry;2024-07

5. Osimertinib Plasma Trough Concentration in Relation to Brain Metastases Development in Patients With Advanced EGFR-Mutated NSCLC;JTO Clinical and Research Reports;2024-04